 In these studies, women treated with  TARGIT-IORT  during lumpectomy for breast cancer combined with whole breast radiotherapy had a significantly low mortality from non-breast-cancer causes, such as cardiovascular and lung complications, as well as other cancers compared with those who received whole breast radiotherapy. Therefore, this reduction was thought to be due to the delivery of TARGIT-IORT to the fresh tumour bed during the trauma of surgery rather than avoidance of scattered radiation from whole breast radiotherapy .
<meaning-changed>  In these studies, women treated with  TARGIT-IORT  during lumpectomy for breast cancer combined with whole breast radiotherapy had a significantly low mortality from non-breast-cancer causes, such as cardiovascular and lung complications, as well as other cancers compared with those who received whole breast radiotherapy. Therefore, this reduction was thought to be due to the delivery of TARGIT-IORT to the fresh tumour bed during the trauma of surgery rather than avoidance of scattered radiation from whole breast radiotherapy .
 In these studies, women treated with TARGIT-IORT during lumpectomy for breast cancer completed in 2012, with long-term follow-up ongoing .